<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider

June 10, 2015

Lake Forest, CA, June 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been selected by Lynden International (“Lynden”) as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.

Read More


Tags: Clinical Trials Logistics, cryogenic frozen, Global Cold Chain Logistics, Lynden

Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015

February 5, 2015

LAKE FOREST, CA – February 5, 2015 — Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, Frozen, Life Sciences, CYRX 3Q FY15 Earnings Release

Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th

January 29, 2015

Lake Forest, CA, January 29, 2015 - Cryoport, Inc. (OTCBB:CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th.  

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, shipping solution, Frozen, sales force, Life Sciences

Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand

January 26, 2015

Lake Forest, CA, January 26, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, shipping solution, Frozen, sales force, Life Sciences

Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team

January 20, 2015

Lake Forest, CA, January 20, 2015 - Cryoport, Inc. (OTCBB: CYRX) ( “Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, board, shipping solution, Frozen

Cryoport Appoints Richard J. Berman to its Board of Directors

January 12, 2015

Lake Forest, CA, January 12, 2015 - Cryoport, Inc. (OTC BB:CYRX) (“Company”), the leading provider of advanced  cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations , vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, board, shipping solution, Frozen, Richard J. Berman

Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015

November 12, 2014

LAKE FOREST, CA – November 12, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue, fiscal 2015

Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry

November 3, 2014

Lake Forest, CA, November 3, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, Frozen Shipping, frozen shipping solution, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, UPS

Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe

September 16, 2014

LAKE FOREST, CA – September 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the world’s leading provider of advanced cryogenic logistics solutions for the life-sciences industry, announced today that it has engaged Broekman Group, a global logistics company headquartered in Rotterdam, the Netherlands, to provide support to their rapidly expanding European client base. According to the terms of the agreement, Broekman’s European operations will support Cryoport’s leading-edge cryogenic logistics solutions throughout Europe.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Europe, Broekman Group

Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force

September 8, 2014

LAKE FOREST, CA – September 8, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport’s new business development personnel will support the Company’s rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, sales, business development, Curt Kole, VP of Strategic Business Development